Compare Cytokinetics Inc (CYTK) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Enveric Biosciences Inc — how do they compare? Cytokinetics Inc trades at $77 (market cap $10.63B), while Enveric Biosciences Inc trades at $1.56 (market cap $6.20M). The key difference: Cytokinetics Inc is far larger — about 1714.5× Enveric Biosciences Inc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | ENVB | |
|---|---|---|
Market Cap | $10.63B | $6.20M |
Sector | Technology | Health |
52-Week High | $87.26 | $17.40 |
52-Week Low | $34.31 | $1.27 |
Enterprise Value | $10.74B | $1.30M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
